Calculating Days’ Supply – Pancreatic Enzymes
Auditors target pancreatic enzyme prescriptions like Creon® and Zenpep® due to high cost and ambiguous directions.
Become an audit assistance member today to continue reading this article. As a member, you’ll have access to hundreds of articles and receive our monthly proactive newsletter!
Directions are often vague and only indicate how many capsules to be taken with meals and snacks. Pharmacies can generally assume three meals, but if the prescription does not specify how many snacks a patient is allowed, or the maximum number of capsules per day, an auditor will look to recoup for “non-specific directions.”
The solution to this problem is contacting the prescriber at the time of fill to clarify the number of snacks or the maximum daily dose and make a clinical note on the prescription. This information must also be added to the patient label to avoid possible recoupment for a “misfill” on audit.
PAAS Tips:
- The pancreatic enzyme category includes Creon®, Zenpep®, Pancreaze®, and Viokace®
- Bottles of Creon® 3,000 UDP, NDC 00032-1203-70, must be stored and dispensed in the original container
- Perform self-audits on a regular basis to ensure accuracy and that days’ supply is calculable
- Read the October 2023 Newsline article, Auditors’ Latest Trick for Flagging “Misfilled” Prescriptions
- Read the October 2023 Newsline article, Use As Directed – What is Your Attack Plan?
Analyst at PAAS National®
I grew up in a family of nurses and other medical professionals but was never interested in the clinic setting. I was drawn to pharmacy because I like to help people and could easily use the knowledge I grew up with to do so. It was a great fit.
I have a Bachelor of Arts in Communications from the University of Wisconsin – Madison. Prior to joining PAAS in 2017, I worked for Walgreens for 19 years.
As an Analyst at PAAS, I really enjoy being able to help independent pharmacies succeed. I have always been a fan of the underdog and am excited to be able to give you the tools you need to take on the giants of the PBM industry.
I have a Bachelor of Arts in Communications from the University of Wisconsin – Madison. Prior to joining PAAS in 2017, I worked for Walgreens for 19 years.
As an Analyst at PAAS, I really enjoy being able to help independent pharmacies succeed. I have always been a fan of the underdog and am excited to be able to give you the tools you need to take on the giants of the PBM industry.
Latest posts by Jenevra Azzopardi, CPhT (see all)
- Representative NDC on Electronic Prescriptions Do Not Infer Specificity - November 24, 2024
- Insulin Pens: Understanding Dosing Increments and Audit Risks - October 9, 2024
- What to Do (and Not Do) When Your Days’ Supply is Rejected - October 7, 2024
